The National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), awarded a single-award Indefinite Delivery Contract (IDC) worth up to $995,714.50 to Avkare LLC, a pharmaceutical distribution company. The IDC is for the supply of teriflunomide tablets, a medication used to treat relapsing forms of multiple sclerosis, to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS).
The period of performance is one year from December 23, 2023, to December 22, 2024, with four one-year option periods. Avkare, a for-profit limited liability company, will distribute the teriflunomide 14mg and 7mg tablets through the VA and DoD's Pharmaceutical Prime Vendor Programs. The estimated annual requirements are 11,883 bottles of the 14mg tablets and 1,508 bottles of the 7mg tablets. This IDC award is the result of a pre-solicitation notice for an unrestricted procurement, with the formal solicitation expected to be issued around August 22, 2023, and a tentative closing date of September 5, 2023.
Generated 12/28/24, 9:08 AM